Cancer Treatment Options from Fairfield

A Cancer diagnosis is not the death knell that it used to be.

Despite being the second leading cause of death in the world, significant progress has been made to combat the disease over the last few decades.

Thanks to constant innovation by the international Scientific community, great steps have been taken in both the prevention of cancer growth and removal of cancerous tumours.

In the United Kingdom we have the good fortune of having access to free medical treatment, however, for those with the financial resources, private healthcare can offer a treatment alternative that gives the patient an increased degree of comfort and security. Fairfield Independent Hospital ( in St. Helens is one such institution.

One of the last few remaining charitable hospitals in the UK, Fairfield offers a wide range of treatments making use of state-of-the-art equipment and some of the best staff. In addition to upgraded patient services, the hospital has recently invested in a brand new digital mammogram that serves to complement their already impressive breast services.

The 32 en-suite room facility is fitted with 2 modern surgical theatres as well as a therapeutic roof top garden. Fairfield’s consultants specialise in a wide range of fields including cosmetic surgery, weight-loss and treatments, such as knee replacements, that are becoming more and more popular as our population continues to grow older.

The Hospital also has a number of treatments and courses that are of particular interest to those diagnosed with cancer, or who have already been identified as being at risk of developing a disease. 

Clinical Hypnotherapy

Fairfield’s specialist hypnotherapist, Russell Hoyles, has been helping patients create positive change in their lives for the last 32 years. It’s often the case that certain lifestyle choices, such as an addiction to smoking or obesity, can lead to the development of cancers. Russell works with patients to try and eradicate these behaviours, to give them a better chance of beating their health issues.

Photodynamic Therapy

When a lesion or a growth is first discovered by a physician, it might not necessarily be cancerous. Steps can be taken before the growth in question develops cancerous qualities. When a condition is discovered, such as Basal Cell Carsionoma (BCC) or Bowen’s Disease; Photodynamic Therapy can be used to treat cosmetically sensitive parts of the body (such as the face or nose).

Surgical Removal

Depending on the development and condition of the lesion, surgery can be used to attempt to remove the entirety of the cancerous growth. This is one of the most effective courses of treatment for cancers that have yet to spread to other parts of the body. Surgical excisions can be used to treat BCCs, but is also a sound procedure for larger lesions and cancerous growths.

Laser Removal

Lastly, a quick and cost-effective therapy to the above two treatments, laser removal can be considered to be an in-out treatment, taking only 20 minutes and requiring minimum post-treatment care. Professor Kayvan Shokrollahi, the Consultant Burns, Plastic and Laser Surgeon at Fairfield has a strong focus on safety and pursues the very best cosmetic results.

As with all medical treatments, it’s always best to consult a number of physicians and institutions, before making your final decision.

If you’re looking for hospitals that specialise in certain treatments, check out our Resources & Links page to find out more information. 


Continue reading »

A New Five-Year Strategy for Cancer Research

The NCRI launch their five-year strategy, Cancer patients skip the GP and one man makes an incredible recovery…

The National Cancer Research Institute has launched it’s five-year strategy today, with the hope of accelerating research into Cancer through meaningful collaboration.

Last year the national partnership, that brings together the 19 biggest fundraisers of cancer research, organised over 250 meetings with the aim of sharing goals amongst private and public sectors.

Karen Kennedy, the Director of the NCRI, has come forward to stress the ‘urgent need for collaboration to fund research that addresses the complex needs of cancer patients at every stage of their journey through and beyond cancer’.

By combining the individual strengths of each organisation, the NCRI has been able to address problems in research that would have otherwise gone unsolved. Over £6 billion has been spent on cancer research since the partnership was first set up back in 2001.

In other news…

A study, funded by Cancer Research UK and published in the British Journal of General Practice, has revealed that approximately one third of patients diagnosed with cancer as an emergency in England had not seen their GP before.

This information coincides with a similar report, assessing Cancer in-patients in North East Scotland, where 28% of all patients also went straight to the emergency room before talking to their doctor.

Further analysis of these two reports have revealed worrying statistics concerning the way potential cancer patients are being treated at initial GP meetings. Of the 1,800 patients that were involved in the Scottish report, around 1 in 5 were diagnosed with cancer as an emergency. Generally speaking, emergency cancer diagnoses often lead to later stage diseases and weaker survival rates.

Jodie Moffat, head of early diagnosis for Cancer Research UK had this to say:

‘For some patients, emergency presentation may be difficult to avoid, but for others there are often things that could have been done differently. Studies like this help us to understand this complex picture and identify what to change’.

And finally…

A piece of good news mined from the depths of 2016, a year that was declared to be ‘the worst ever’.

In 2011, Mike Chettle was diagnosed with late-stage bowel cancer which soon spread to his bone, liver and abdomen. Three years later, despite several serious operations, Mike found himself in constant pain and virtually paralysed by his illness.

Relentless rounds of chemotherapy did little to help, leaving him with the daunting prospect of facing end of life care. Before he gave up hope, however, his doctor gave him one more option. Mike took part in a radical trial, using the drug pembrolizumab – two years later and the 26 tumours that once covered his body have now virtually disappeared.

This is a particular case that is purpose built to raise hopes. On the edge of death, Mike was able to make a huge recovery and even walk down his daughter down the aisle, a feat that would have been unfeasible before the introduction of this groundbreaking drug.

Tests will continue, with the hope that these incredible results can be replicated on a larger scale.

Continue reading »